FDA's next-gen medtech surveillance bets heavily on unique device identifiers-massdevice: The FDA laid out plans to revamp its postmarket surveillance of medical devices, and a large part of that has to do with finalizing and implementing a long-awaited Unique Device Identifier program to better track and monitor devices.
Thursday, April 25, 2013
FDA's next-gen medtech surveillance bets heavily on unique device identifiers
FDA's next-gen medtech surveillance bets heavily on unique device identifiers-massdevice: The FDA laid out plans to revamp its postmarket surveillance of medical devices, and a large part of that has to do with finalizing and implementing a long-awaited Unique Device Identifier program to better track and monitor devices.
